Ketorolac

Generic Name
Ketorolac
Brand Names
Acular, Acuvail, Omidria, Readysharp Anesthetics Plus Ketorolac, Sprix, Toradol, Toronova Suik
Drug Type
Small Molecule
Chemical Formula
C15H13NO3
CAS Number
74103-06-3
Unique Ingredient Identifier
YZI5105V0L
Background

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and is commercially available as an oral tablet, injectable, nasal spray and as an ophthalmic solution.

It's analgesic properties make it a useful pain management tool across many settings including postoperative pain, rheumatoid arthritis, osteoarthritis, menstrual disorders, headaches, spinal and soft tissue pain, and ankylosing spondylitis. Impressively, ketorolac has a similar efficacy to standard doses of morphine and meperidine making it a useful opioid sparing agent.

Indication

Ketorolac is a Non-steroidal anti-inflammatory drug (NSAID) and has antipyretic, analgesic and anti-inflammatory properties. It is indicated for short term management of acute pain that requires the calibre of pain management offered by opioids. Clinicians may choose to initiate ketorolac to manage post-operative pain, spinal and soft tissue pain, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, menstrual disorders and headaches among other ailments. Regardless of the etiology of pain, patients should use the lowest possible dose, and avoid using ketorolac for an extended period of time (ideally ≤ 5 days). A benefit of choosing ketorolac over other analgesics with similar potency is that that there does not appear to be a risk of dependence or tolerance with ketorolac use.

Associated Conditions
Acute Migraine, Eye Pain, Inflammation, Macular Edema, Cystoid, Ocular Itching, Pericarditis Acute, Pseudophakic Cystoid Macular Oedema, Severe Acute Pain, Acute, moderate Pain, Chronic aphakic cystoid macular edema, Intraoperative miosis, Postoperative ocular pain
Associated Therapies
-

Enhanced Recovery at Cesarean Birth to Improve Postoperative Outcomes and Reduce Postoperative Length of Stay

First Posted Date
2016-11-06
Last Posted Date
2019-04-25
Lead Sponsor
Montefiore Medical Center
Target Recruit Count
118
Registration Number
NCT02956616
Locations
🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Ketorolac Premedication for Anesthetic Efficiency of IANB & Postendodontic Pain in Teeth With Irreversible Pulpitis

First Posted Date
2016-10-20
Last Posted Date
2016-10-21
Lead Sponsor
Cairo University
Target Recruit Count
38
Registration Number
NCT02940405

Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2016-10-19
Last Posted Date
2016-10-19
Lead Sponsor
Shahid Beheshti University of Medical Sciences
Target Recruit Count
40
Registration Number
NCT02937896

Premedication Efficacy of Ketorolac Infiltration on Post Endodontic Pain

First Posted Date
2016-10-04
Last Posted Date
2019-01-15
Lead Sponsor
Azad University of Medical Sciences
Target Recruit Count
60
Registration Number
NCT02923687
Locations
🇮🇷

Dental Branch, AZad UMS, Tehran, Iran, Islamic Republic of

Intravenous Lidocaine and Ketorolac for Pain Management

First Posted Date
2016-09-16
Last Posted Date
2020-03-18
Lead Sponsor
Antonios Likourezos
Target Recruit Count
150
Registration Number
NCT02902770

Treatment of Acute Pancreatitis With Ketorolac

Phase 4
Terminated
Conditions
Interventions
First Posted Date
2016-08-31
Last Posted Date
2019-05-15
Lead Sponsor
Ilam University of Medical Sciences
Target Recruit Count
56
Registration Number
NCT02885441
Locations
🇮🇷

Ilam University of Medical Scienvc, Ilam, Iran, Islamic Republic of

The Impact of IV Acetaminophen on Pain After Appendectomy for Perforated Appendicitis

First Posted Date
2016-08-29
Last Posted Date
2021-01-12
Lead Sponsor
Children's Mercy Hospital Kansas City
Target Recruit Count
90
Registration Number
NCT02881996
Locations
🇺🇸

Children's Mercy Hospital, Kansas City, Missouri, United States

Pain Management in Corneal Collagen Crosslinking for Keratoconus

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-08-15
Last Posted Date
2016-08-15
Lead Sponsor
Instituto de Oftalmología Fundación Conde de Valenciana
Target Recruit Count
25
Registration Number
NCT02867176

Impact of Local Anesthetic Wound Infiltration on Postoperative Pain Following Cesarean Delivery

Phase 4
Completed
Conditions
Interventions
First Posted Date
2016-07-12
Last Posted Date
2020-03-06
Lead Sponsor
Duke University
Target Recruit Count
84
Registration Number
NCT02829944
Locations
🇺🇸

Duke University Hospital, Durham, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath